Satori Vibracoustic Wellness System — Resistant Patient Population

Methodology

64 adolescent and young-adult females in a residential eating disorder treatment program — a known resistant patient population — received Satori Vibracoustic Wellness System audio therapy sessions. Symptom Intensity Scale (SIS) forms were completed before and immediately after each session, tracking eight key emotional and physical symptom categories.

Key Findings

• 35–49% symptom decrease per session

• Largest reductions in tenseness (49.4%), fear (45.9%), and body aches (46%)

• 40–47% improvement in initial session across eight key categories

• Effective results even in patients where other therapies are less effective

• Consistent symptom reduction across all eight measured categories

Clinical Results

Study demonstrated that Satori Vibracoustic Wellness System therapies provide significant reductions across emotional and physical symptoms in a resistant patient population, proving merit as adjunctive treatment when other therapies are less effective.

Full Study

This study was conducted at The Renfrew Center in Coconut Creek, FL, specifically targeting a resistant patient population — adolescent and young-adult females (ages 13–25) in a residential eating disorder program who had shown limited responsiveness to conventional therapies.

64 participants received Satori Vibracoustic Wellness System audio therapy sessions. Each subject completed a Symptom Intensity Scale (SIS) form documenting symptom levels prior to and immediately following each session, tracking eight key categories: stress, anxiety, fearfulness, anger, depression, moodiness, tension, and body aches.

Results showed 35–49% symptom decreases per session, with the largest reductions in tenseness (49.4%), fear (45.9%), and body aches (46%). In initial sessions, improvements averaged 40–47% across the eight key categories.

The significance of this study lies in its resistant population. Where many conventional therapeutic approaches showed limited efficacy, audio therapy produced consistent and measurable reductions in both emotional and physical symptoms — demonstrating its particular value as an adjunct modality when other treatments fall short.

Research disclosure. The studies referenced on this page were conducted under Theracoustic™, a trading name of the same company and team behind WellAudio, using the same underlying audio therapy technology and methodology. WellAudio is a new consumer product built on this foundation. These studies were carried out prior to the launch of WellAudio and were not performed using this application specifically. Results reflect outcomes from clinical and institutional settings and may not be representative of individual consumer use.